Factors associated with the use of the prescription monitoring program by prescribers and pharmacists in Texas.
James Douglas ThorntonTyler J VariscoCallie G DownsPublished in: Pharmacoepidemiology and drug safety (2021)
Changes in PMP utilization between October 2016 and December 2018 were driven by increasing registration, not increasing frequency of use among registered users. Use of the PMP is inconsistent and dependent upon patient characteristics thus limiting the utility of the PMP as a decision support tool. These results support the need for policy mandating PMP use in Texas and provide a useful baseline and framework to evaluate the effectiveness of mandate implementation.